Loading...
6615 logo

Sofiva Genomics Co.,Ltd.TPEX:6615 Stock Report

Market Cap NT$797.9m
Share Price
n/a
1Y12.0%
7D1.9%
1D-0.3%
Portfolio Value
​
View

Sofiva Genomics Co.,Ltd.

TPEX:6615 Stock Report

Market Cap: NT$797.9m

Sofiva GenomicsLtd (6615) Stock Overview

Provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. More details

6615 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Rewards

Earnings grew by 211.1% over the past year

Risk Analysis

Earnings have declined by 42.1% per year over past 5 years

Does not have a meaningful market cap (NT$798M)


6615 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW501,009 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
501,009 investors already sharing narratives
View all narratives

Sofiva Genomics Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sofiva GenomicsLtd
Historical stock prices
Current Share PriceNT$36.95
52 Week HighNT$40.00
52 Week LowNT$28.90
Beta0.19
1 Month Change7.10%
3 Month Change8.04%
1 Year Change11.97%
3 Year Change-4.89%
5 Year Change-25.50%
Change since IPO-59.40%

Recent News & Updates

Recent updates

Analysis Article • Apr 14

Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
Analysis Article • Mar 18

Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)

In this article we are going to estimate the intrinsic value of Sofiva Genomics Co.,Ltd. ( GTSM:6615 ) by taking the...
Analysis Article • Feb 24

Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend

Dividend paying stocks like Sofiva Genomics Co.,Ltd. ( GTSM:6615 ) tend to be popular with investors, and for good...
Analysis Article • Jan 27

Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

It is hard to get excited after looking at Sofiva GenomicsLtd's (GTSM:6615) recent performance, when its stock has...
Analysis Article • Jan 07

Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Analysis Article • Dec 15

A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)

Does the December share price for Sofiva Genomics Co.,Ltd. ( GTSM:6615 ) reflect what it's really worth? Today, we will...
Analysis Article • Nov 24

Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend

Today we'll take a closer look at Sofiva Genomics Co.,Ltd. (GTSM:6615) from a dividend investor's perspective. Owning...

Shareholder Returns

6615TW HealthcareTW Market
7D1.9%1.8%3.7%
1Y12.0%-18.3%106.2%

Return vs Industry: 6615 exceeded the TW Healthcare industry which returned -18.3% over the past year.

Return vs Market: 6615 underperformed the TW Market which returned 106.2% over the past year.

Price Volatility

Is 6615's price volatile compared to industry and market?
6615 volatility
6615 Average Weekly Movement4.4%
Healthcare Industry Average Movement4.5%
Market Average Movement6.4%
10% most volatile stocks in TW Market12.1%
10% least volatile stocks in TW Market2.6%

Stable Share Price: 6615 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6615's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012n/aChia-Cheng Hungwww.sofivagenomics.com.tw

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessment for early/late-onset preeclampsia, folate metabolism genetic testing, congenital infection screening,carrier scan, thalassemia genetic testing, spinal muscular atrophy genetic testing, and fragile X syndrome genetic testing.

Sofiva Genomics Co.,Ltd. Fundamentals Summary

How do Sofiva GenomicsLtd's earnings and revenue compare to its market cap?
6615 fundamental statistics
Market capNT$797.88m
Earnings (TTM)NT$8.39m
Revenue (TTM)NT$382.82m
95.1x
P/E Ratio
2.1x
P/S Ratio

Is 6615 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6615 income statement (TTM)
RevenueNT$382.82m
Cost of RevenueNT$282.18m
Gross ProfitNT$100.64m
Other ExpensesNT$92.25m
EarningsNT$8.39m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.39
Gross Margin26.29%
Net Profit Margin2.19%
Debt/Equity Ratio0%

How did 6615 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 00:52
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sofiva Genomics Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yenya KuoCapital Securities Corporation
Xiaowei HuangMasterlink Securities Investment Advisory